Last updated
Revenue
R&D Expenses
Operating CF
Total Assets
Total Liabilities
Equity
Shares Out.
D/E Ratio
Dilution Watch
Financials
52W LOW $0.0352W HIGH $0.28
Volume
195.07 K
Value Traded
19.51
Short % Float
0%
Days to Cover
1.0
-99.63%5 Year
-99.63%All Time
Cash Data
- Monthly Burn
- Burn Trend
- Dilution Risk
- SEC Filing
Key Stats
Market Cap
2.67 M
EPS (TTM)
-1.12
P/E Ratio
-
Ent. Value
-
Total Shares
-
Float Shares
-
Insiders
0.00%
Institutions
0.00%
Upcoming Catalysts
FDA decisions, readouts and PDUFA dates · scored by probability of approval
| Catalyst | Drug / Treatment | Stage | Prob. of Approval | Description | Drug Type | Therapeutic Area | Source |
|---|
PoA blends historical approval base rates, trial design score and FDA review track record.
AFIB Catalyst Timeline
Dated clinical, regulatory and corporate events for Acutus Medical, Inc.
Past FDA Catalysts and PDUFA Decisions
How AFIB actually traded into and out of each decision
| Date | Drug | Catalyst | Stage | Reaction | Event Move % | Best Trade % |
|---|---|---|---|---|---|---|
| No matching catalysts | ||||||
Reaction: 30 trading days around the event · Event Move: close to close on decision day · Best Trade: peak run-up from entry 10 days before the decision
Drug Pipeline Intelligence
No drug pipeline
Acutus Medical, Inc. is a medical device company. The clinical trials it takes part in test other companies' drugs, so it has no drug pipeline of its own to score.
Clinical Trial Results
Readouts, endpoints and source filings for every AFIB program
| Drug Name | Indication | Phase | Date | Trial Results Summary | Title | Source |
|---|
Inside Trades
| Insider | Side | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Huennekens R ScottDirector | Sell | -60,000 507,509 held | $0.58 | 06/03/2022 |
Hedge Fund 13F Activity
Hedge Funds invested in AFIB
| Fund | % of Portfolio | Current MV | Shares Owned | Activity |
|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 0 % | 497.90 K | 2.65 M |
Ownership Trends
AFIB Short Interest
Shares sold short, counted twice a month.
0%
Short % of Float
of tradable shares sold short
871
Shares Sold Short
0.0% vs prior count
1.0 Low
Days to Cover
trading days of normal volume to buy every short share back
12.4K
Avg Daily Volume
the average used for days to cover
Options Data
Option Volume
Open Interest
Call OI
Put OI
Put-Call Ratio
OI 30-day avg
Today vs avg
Option Volume
Call Vol
Put Vol
Put-Call Ratio
Vol 30-day avg
Today vs avg
Option Chain Statistics
| Expiry | Call Vol | Put Vol | Vol P/C | Call OI | Put OI | OI P/C | IV Call | IV Call OI-Wtd | IV Call Vol-Wtd | IV Put | IV Put OI-Wtd | IV Put Vol-Wtd |
|---|
Real-Time Option Chain
| Calls | Strike | Puts | ||||
|---|---|---|---|---|---|---|
| Last | Vol | OI | Last | Vol | OI | |
| No data available | ||||||
Calls vs Puts by Expiry
CallsPutsLog scale
Competitive positioning
How AFIB ranks across every disease it competes in
Competitive Position is a premium feature
See how AFIB ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trialAFIB News
AFIBAcutus Medical Reports Full Year 2024 Financial Results
Acutus Medical Reports Full Year 2024 Financial Results CARLSBAD, Calif., March 24, 2025 (GLOBE NEWSWIRE) - Acutus Medical, Inc. ("Acutus" or the "Company") (OTC AFIB) today reported results for the full year of 2024. 2024 Revenue from Continuing Operations of $20.2 million gre
Read more →AFIB▲ +16.3%on this news
Acutus Medical Announces Operational Downsizing
Acutus Medical Announces Operational Downsizing CARLSBAD, Calif., December 4, 2024 (GLOBE NEWSWIRE) - Acutus Medical, Inc. ("Acutus" or the "Company") (Nasdaq: AFIB), today announced a realignment of resources and operational downsizing. Dr. Shaden Marzouk, Chairperson of the
Read more →AFIB▲ +14.1%on this news
Acutus Medical Reports Third Quarter and Year-To-Date 2024 Financial Results
Acutus Medical Reports Third Quarter and Year-To-Date 2024 Financial Results CARLSBAD, Calif., November 14, 2024 (GLOBE NEWSWIRE) - Acutus Medical, Inc. ("Acutus" or the "Company") (OTC AFIB) today reported results for the third quarter and year-to-date of 2024. Third quarter r
Read more →AFIB▲ +6.4%on this news
Acutus Medical Reports Second Quarter and Year-To-Date 2024 Financial Results
Acutus Medical Reports Second Quarter and Year-To-Date 2024 Financial Results CARLSBAD, Calif., August 8, 2024 (GLOBE NEWSWIRE) - Acutus Medical, Inc. ("Acutus" or the "Company") (OTC AFIB) today reported results for the second quarter and year-to-date of 2024. Second quarter r
Read more →AFIB▼ -33.9%on this news· ran to -54% by day 1
Acutus Medical Reports First Quarter 2024 Financial Results
Acutus Medical Reports First Quarter 2024 Financial Results CARLSBAD, Calif., May 9, 2024 (GLOBE NEWSWIRE) - Acutus Medical, Inc. ("Acutus" or the "Company") (OTC AFIB) today reported results for the first quarter of 2024. First quarter revenue from Continuing Operations of $3.
Read more →AFIBAcutus Medical Reports Fourth Quarter and Full Year 2023 Financial Results
Acutus Medical Reports Fourth Quarter and Full Year 2023 Financial Results CARLSBAD, Calif., April 1, 2024 (GLOBE NEWSWIRE) - Acutus Medical, Inc. ("Acutus" or the "Company") (Nasdaq AFIB) today reported results for the fourth quarter and full year ended December 31,2023. Annou
Read more →AFIB▼ -16.4%on this news· ran to -64% by day 3
Acutus Medical Reports Third Quarter 2023 Financial Results
Medical Reports Third Quarter 2023 Financial Results CARLSBAD, Calif., November 8, 2023 (GLOBE NEWSWIRE) - Acutus Medical, Inc. ("Acutus" or the "Company") (Nasdaq: AFIB) today reported results for the third quarter of 2023. Third Quarter 2023 Financial Results Revenue was $5
Read more →AFIBAcutus Medical Reports Second Quarter 2023 Financial Results
Acutus Medical Reports Second Quarter 2023 Financial Results CARLSBAD, Calif., August 7, 2023 (GLOBE NEWSWIRE) - Acutus Medical, Inc. ("Acutus" or the "Company") (Nasdaq AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and tr
Read more →AFIBAcutus Medical Reports First Quarter 2023 Financial Results
Acutus Medical Reports First Quarter 2023 Financial Results CARLSBAD, Calif., May 11, 2023 (GLOBE NEWSWIRE) - Acutus Medical, Inc. ("Acutus" or the "Company") (Nasdaq AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treat
Read more →AFIBAcutus Medical Announces Preliminary Unaudited First Quarter 2023 Results Carlsbad, Calif.
Exhibit 99.1 Press Release Acutus Medical Announces Preliminary Unaudited First Quarter 2023 Results Carlsbad, Calif. - April 20, 2023 - Acutus Medical, Inc. ("Acutus" or the "Company") (Nasdaq AFIB), an arrhythmia management company focused on improving the way cardiac arrhy
Read more →AFIB▼ -7.5%on this news· ran to -23% by day 3
Acutus Medical Announces Preliminary Unaudited Fourth Quarter and Full Year 2022 Results and Appointment of Chief Financial Officer Carlsbad, Calif.
Exhibit 99.1 Press Release Acutus Medical Announces Preliminary Unaudited Fourth Quarter and Full Year 2022 Results and Appointment of Chief Financial Officer Carlsbad, Calif. - January 9, 2023 -- Acutus Medical, Inc. ("Acutus" or the "Company") (Nasdaq AFIB), an arrhythmia m
Read more →AFIBAcutus Medical Reports Third Quarter 2022 Financial Results Carlsbad, Calif.
Exhibit 99.1 Press Release Acutus Medical Reports Third Quarter 2022 Financial Results Carlsbad, Calif. - November 10, 2022 - Acutus Medical, Inc. ("Acutus" or the "Company") (Nasdaq AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are
Read more →AFIB▲ +39.7%on this news
Caution Regarding Forward-Looking Statements This press release includes statements that may constitute "forward-looking" statements, usually containing the words "believe," "estimate," "project," "expect"
Exhibit 99.1 Press Release Acutus Medical Achieves OEM Qualification Milestone in Sale of Left-Heart Access Portfolio to Medtronic Carlsbad, Calif. - November 3, 2022 - Acutus Medical, Inc. ("Acutus" or the "Company") (Nasdaq AFIB), an arrhythmia management company focused
Read more →AFIBUnaudited Pro Forma Condensed Consolidated Financial Information Overview On
Forma Condensed Consolidated Financial Information June 30, 2022 (the "Effective Date"), Acutus Medical, Inc. ("Acutus" or the "Company") completed its previously announced transaction with Medtronic, Inc. (together with its affiliates, "Medtronic"), in accordance with the Ass
Read more →AFIBAcutus Medical Reports Second Quarter 2022 Financial Results Carlsbad, Calif.
Exhibit 99.1 Press Release Acutus Medical Reports Second Quarter 2022 Financial Results Carlsbad, Calif. - August 11, 2022 - Acutus Medical, Inc. ("Acutus" or the "Company") (Nasdaq AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are d
Read more →AFIB▲ +18.7%on this news
Acutus Medical Announces CEO Appointment and Preliminary Second Quarter Revenue Results
Acutus Medical Announces CEO Appointment and Preliminary Second Quarter Revenue Results CARLSBAD, Calif., July 21, 2022 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. ("Acutus" or the "Company") (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac a
Read more →AFIB▲ +5%on this news
Acutus Medical Reports First Quarter 2022 Financial Results and CEO Transition Carlsbad, Calif.
Exhibit 99.1 Press Release Acutus Medical Reports First Quarter 2022 Financial Results Carlsbad, Calif. - May 12, 2022 - Acutus Medical, Inc. ("Acutus" or the "Company") (Nasdaq AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagn
Read more →AFIB▲ +36%on this news
Acutus Medical Announces Agreements to Fund Strategic Growth Priorities Carlsbad, Calif.
Announces Agreements to Fund Strategic Growth Priorities Calif. - April 27, 2022 - Acutus Medical, Inc. ("Acutus" or the "Company") (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today announced a com
Read more →AFIBAcutus Medical Reports Fourth Quarter and Full Year 2021 Financial Results Carlsbad, Calif.
Exhibit 99.1 Press Release Acutus Medical Reports Fourth Quarter and Full Year 2021 Financial Results Carlsbad, Calif. - March 30, 2022 - Acutus Medical, Inc. ("Acutus" or the "Company") (Nasdaq AFIB), an arrhythmia management company focused on improving the way cardiac arrh
Read more →About Acutus Medical, Inc.
Headquarters2210 Faraday Avenue
Founded06-08-2020
BIOPHARMAWATCH ELITE
Trade the next AFIB catalyst before the market reprices
Every FDA decision, PoA score, 13F move and dilution flag on this page, for 1,100+ biotech tickers. From $24/mo billed annually.
Cancel anytime